Design, synthesis, and in vitro evaluation of new amphiphilic cyclodextrin-based nanoparticles for the incorporation and controlled release of acyclovir

Florent Perret1, Marine Duffour1, Yves Chevalier2, Hélène Parrot-Lopez1
1ICBMS UMR CNRS, CSAp, Université Lyon 1, Villeurbanne cedex, France
2Laboratoire d’Automatique et de Génie des Procédés, UMR CNRS, Université Lyon 1, Villeurbanne cedex, France

Tài liệu tham khảo

Uekama, 1998, Cyclodextrin drug carrier systems, Chem. Rev., 98, 2045, 10.1021/cr970025p Duchêne, 1991 Loftsson, 2007, Cyclodextrins and their pharmaceutical applications, Int. J. Pharm., 329, 1, 10.1016/j.ijpharm.2006.10.044 Falvey, 2005, Bilayer vesicles of amphiphilic cyclodextrins: host membranes that recognize guest molecules, Chem. Eur. J., 11, 1171, 10.1002/chem.200400905 Dubes, 2003, Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins, Eur. J. Pharm. Biopharm., 55, 279, 10.1016/S0939-6411(03)00020-1 Memişoğlu, 2003, Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes, Pharm. Res., 20, 117, 10.1023/A:1022263111961 Ling, 1993, Cyclodextrin liquid crystals: synthesis and self-organisation of amphiphilic thio-β-cyclodextrins, J. Chem. Soc., Chem. Commun., 438, 10.1039/C39930000438 N. Terry, D. Rival, E. Perrier, A.W. Coleman, Use of Cyclodextrin Derivatives for Skin Preparations, etc., Their Micelles or Nanoparticles, and Compositions Containing the Derivatives, French Patent, FR 2000-6102, 2001. Dubes, 2001, An efficient regiospecific synthetic route to multiply substituted acyl-sulphated β-cyclodextrins, Tetrahedron Lett., 42, 9147, 10.1016/S0040-4039(01)01992-X Krafft, 2001, Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research, Adv. Drug Deliver Rev., 47, 209, 10.1016/S0169-409X(01)00107-7 Riess, 2009, Highly fluorinated amphiphilic molecules and self-assemblies with biomedical potential, Curr. Opin. Colloid Interface Sci., 14, 294, 10.1016/j.cocis.2009.05.008 Gadras, 1999, Improved stability of highly fluorinated phospholipid-based vesicles in the presence of bile salts, J. Control. Release, 57, 29, 10.1016/S0168-3659(98)00109-6 Guittard, 2001, Highly fluorinated molecular organised systems: strategy and concept, J. Fluorine Chem., 107, 363, 10.1016/S0022-1139(00)00380-8 Skiba, 2002, Design of nanocapsules based on novel fluorophilic cyclodextrin derivatives and their potential role in oxygen delivery, J. Inclus. Phenom. Macro. Chem., 44, 151, 10.1023/A:1023090528809 Peroche, 2005, Synthesis and characterisation of novel nanospheres made from amphiphilic perfluoroalkylthio-β-cyclodextrins, Eur. J. Pharm. Biopharm., 60, 123, 10.1016/j.ejpb.2005.01.005 Bertino-Ghera, 2008, Control of the regioselectivity for novel fluorinated amphiphilic cyclodextrins: synthesis of di- and tetra-(6-deoxy-6-alkylthio) and 6-(perfluoroalkypropanelthio)-α-cyclodextrins derivatives, J. Org. Chem., 73, 7317, 10.1021/jo801111b Bertino-Ghera, 2007, Synthesis and characterisation of O-6-alkylthio- and perfluoroalkylpropanethio-α-cyclodextrins and their O-2-, O-3-methylated analogues, New J. Chem., 31, 1899, 10.1039/b703894a Bertino-Ghera, 2009, Novel nanoparticles made from amphiphilic perfluoroalkyl α-cyclodextrin derivatives: preparation, characterisation and application to the transport of Acyclovir, Int. J. Pharm., 375, 155, 10.1016/j.ijpharm.2009.04.004 Wagstaff Antona, 1994, Aciclovir: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy, Drugs, 47, 153, 10.2165/00003495-199447010-00009 Fresta, 1999, Characterization and in-vivo ocular absorption of liposome-encapsulated acyclovir, J. Pharm. Pharmacol., 51, 565, 10.1211/0022357991772664 Takeo, 1989, Selective chemical modification of cyclomalto-oligosaccharides via tertbutyldimethylsililation, Carbohydr. Res., 187, 203, 10.1016/0008-6215(89)80004-7 Wang, 2011, Synthesis of a novel class of cyclodextrin-based nanotubes, Org. Lett., 13, 3572, 10.1021/ol201065u Von Plessing Rossel, 2000, Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase, Quim. Nova, 23, 749, 10.1590/S0100-40422000000600007 Tomar, 2010, Enhancement of solubility of Acyclovir by solid dispersion and inclusion complexation methods, Der Pharm. Lett., 2, 341 Zielenkiewicz, 2010, Enhancement of aqueous solubility of tricyclic acyclovir derivatives by their complexation with hydroxypropyl-β-cyclodextrin, J. Therm. Anal. Calorim., 101, 555, 10.1007/s10973-010-0847-0 Dubes, 2003, Synthesis and characterisation of sulfated amphiphilic α-, β- and γ-cyclodextrins: application to the complexation of acyclovir, Carbohydr. Res., 338, 2185, 10.1016/S0008-6215(03)00356-2 Cavalli, 2009, Enhanced antiviral activity of Acyclovir loaded into β-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles, J. Control. Release, 137, 116, 10.1016/j.jconrel.2009.04.004 Schalchli, 1993, Structure of a monomolecular layer of amphiphilic cyclodextrins, Langmuir, 9, 1968, 10.1021/la00032a009